Global Tuberculosis Testing
Market Report
2025
Tuberculosis Testing Market Report 2025 (Global Edition)
The global Antithrombin market size will be USD 2980 million in 2025. Rising global prevalence of tuberculosis (TB) and latent TB infections is expected to boost sales to USD 4821.8 million by 2033, with a Compound Annual Growth Rate (CAGR) of 6.20% from 2025 to 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Tuberculosis Testing Market Report 2025.
Global Tuberculosis Testing Market Report 2025 Market Size Split by Test Type Outlook: (Chest X-Ray, Culture-Based Tests, Interferon-Gamma Release Assays (IGRA), Mantoux Test (Tuberculin Skin Test), N...
According to Cognitive Market Research, the global Antithrombin market size will be USD 2980 million in 2025. It will expand at a compound annual growth rate (CAGR) of 6.20% from 2025 to 2033.
- North America held the major market share for more than 37% of the global revenue with a market size of USD 1102.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2033.
- Europe accounted for a market share of over 29% of the global revenue with a market size of USD 864.20 million.
- APAC held a market share of around 24% of the global revenue with a market size of USD 715.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9% from 2025 to 2033.
- South America has a market share of more than 3.8% of the global revenue with a market size of USD 113.24 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033.
- Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 119.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2033.
- Africa had a market share of around 2.20% of the global revenue and was estimated at a market size of USD 65.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2033.
- Xpert Test category is the fastest growing segment of the Antithrombin industry
| 2021 | 2025 | 2033 | CAGR | |
|---|---|---|---|---|
| Global Tuberculosis Testing Market Sales Revenue | 121212 | $ 2980 Million | $ 4821.8 Million | 6.2% |
| North America Tuberculosis Testing Market Sales Revenue | 121212 | $ 1102.6 Million | $ 33.8 Million | 5% |
| United States Tuberculosis Testing Market Sales Revenue | 121212 | $ 869.95 Million | 121212 | 4.8% |
| Canada Tuberculosis Testing Market Sales Revenue | 121212 | $ 132.31 Million | 121212 | 5.8% |
| Mexico Tuberculosis Testing Market Sales Revenue | 121212 | $ 100.34 Million | 121212 | 5.5% |
| Europe Tuberculosis Testing Market Sales Revenue | 121212 | $ 864.2 Million | $ 1277.8 Million | 5% |
| United Kingdom Tuberculosis Testing Market Sales Revenue | 121212 | $ 145.19 Million | 121212 | 5.8% |
| France Tuberculosis Testing Market Sales Revenue | 121212 | $ 79.51 Million | 121212 | 4.2% |
| Germany Tuberculosis Testing Market Sales Revenue | 121212 | $ 171.11 Million | 121212 | 5.2% |
| Italy Tuberculosis Testing Market Sales Revenue | 121212 | $ 74.32 Million | 121212 | 4.4% |
| Russia Tuberculosis Testing Market Sales Revenue | 121212 | $ 133.95 Million | 121212 | 4% |
| Spain Tuberculosis Testing Market Sales Revenue | 121212 | $ 70.86 Million | 121212 | 4.1% |
| Sweden Tuberculosis Testing Market Sales Revenue | 121212 | $ 26.79 Million | 121212 | 5.1% |
| Denmark Tuberculosis Testing Market Sales Revenue | 121212 | $ 18.15 Million | 121212 | 4.8% |
| Switzerland Tuberculosis Testing Market Sales Revenue | 121212 | $ 12.96 Million | 121212 | 4.7% |
| Luxembourg Tuberculosis Testing Market Sales Revenue | 121212 | $ 10.37 Million | 121212 | 5.3% |
| Rest of Europe Tuberculosis Testing Market Sales Revenue | 121212 | $ 120.99 Million | 121212 | 3.7% |
| Asia Pacific Tuberculosis Testing Market Sales Revenue | 121212 | $ 715.2 Million | $ 1422.4 Million | 9% |
| China Tuberculosis Testing Market Sales Revenue | 121212 | $ 300.38 Million | 121212 | 8.5% |
| Japan Tuberculosis Testing Market Sales Revenue | 121212 | $ 98.7 Million | 121212 | 7.5% |
| South Korea Tuberculosis Testing Market Sales Revenue | 121212 | $ 85.82 Million | 121212 | 8.1% |
| India Tuberculosis Testing Market Sales Revenue | 121212 | $ 71.52 Million | 121212 | 10.9% |
| Australia Tuberculosis Testing Market Sales Revenue | 121212 | $ 37.19 Million | 121212 | 8.3% |
| Singapore Tuberculosis Testing Market Sales Revenue | 121212 | $ 14.3 Million | 121212 | 9.3% |
| Taiwan Tuberculosis Testing Market Sales Revenue | 121212 | $ 27.89 Million | 121212 | 8.8% |
| South East Asia Tuberculosis Testing Market Sales Revenue | 121212 | $ 47.2 Million | 121212 | 9.8% |
| Rest of APAC Tuberculosis Testing Market Sales Revenue | 121212 | $ 32.18 Million | 121212 | 8.8% |
| South America Tuberculosis Testing Market Sales Revenue | 121212 | $ 113.24 Million | $ 188.1 Million | 6.5% |
| Brazil Tuberculosis Testing Market Sales Revenue | 121212 | $ 48.47 Million | 121212 | 7.1% |
| Argentina Tuberculosis Testing Market Sales Revenue | 121212 | $ 19.02 Million | 121212 | 7.4% |
| Colombia Tuberculosis Testing Market Sales Revenue | 121212 | $ 10.08 Million | 121212 | 6.3% |
| Peru Tuberculosis Testing Market Sales Revenue | 121212 | $ 9.29 Million | 121212 | 6.7% |
| Chile Tuberculosis Testing Market Sales Revenue | 121212 | $ 8.15 Million | 121212 | 6.8% |
| Rest of South America Tuberculosis Testing Market Sales Revenue | 121212 | $ 18.23 Million | 121212 | 5.6% |
| Middle East Tuberculosis Testing Market Sales Revenue | 121212 | $ 119.2 Million | $ 200.1 Million | 6.7% |
| Qatar Tuberculosis Testing Market Sales Revenue | 121212 | $ 9.54 Million | 121212 | 6.2% |
| Saudi Arabia Tuberculosis Testing Market Sales Revenue | 121212 | $ 41.96 Million | 121212 | 7% |
| Turkey Tuberculosis Testing Market Sales Revenue | 121212 | $ 9.54 Million | 121212 | 7.3% |
| UAE Tuberculosis Testing Market Sales Revenue | 121212 | $ 24.56 Million | 121212 | 7.2% |
| Egypt Tuberculosis Testing Market Sales Revenue | 121212 | $ 7.15 Million | 121212 | 6.5% |
| Rest of Middle East Tuberculosis Testing Market Sales Revenue | 121212 | $ 26.46 Million | 121212 | 5.9% |
| Africa Tuberculosis Testing Market Sales Revenue | 121212 | $ 65.56 Million | $ 103.7 Million | 5.9% |
| Nigeria Tuberculosis Testing Market Sales Revenue | 121212 | $ 5.24 Million | 121212 | 6.1% |
| South Africa Tuberculosis Testing Market Sales Revenue | 121212 | $ 23.08 Million | 121212 | 6.8% |
| Rest of Africa Tuberculosis Testing Market Sales Revenue | 121212 | $ 37.24 Million | 121212 | 5.1% |
| Base Year | 2024 |
| Historical Data Time Period | 2021-2024 |
| Forecast Period | 2025-2033 |
| Market Split by Test Type Outlook: |
|
| Market Split by End User Outlook: |
|
| List of Competitors |
|
| Regional Analysis |
|
| Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
Report scope is customizable as we have a huge database of Tuberculosis Testing industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Tuberculosis Testing Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Tuberculosis Testing Market Report Description
Introduction of the Antithrombin Market
The Tuberculosis Testing Market focuses on the development and adoption of diagnostic technologies to detect Mycobacterium tuberculosis, the bacteria responsible for tuberculosis (TB). These tests are crucial for early diagnosis, treatment monitoring, and controlling the spread of TB, especially in high-burden regions. The market is driven by the increasing prevalence of TB, growing government initiatives for disease control, and advancements in diagnostic methods, including nucleic acid amplification tests (NAATs), interferon-gamma release assays (IGRAs), and AI-powered imaging solutions. Rising demand for rapid, accurate, and cost-effective TB detection has accelerated innovation in automated molecular testing and portable diagnostic devices. Additionally, increasing awareness, funding from global health organizations, and national screening programs are further propelling market growth. As diagnostic technologies evolve, the Tuberculosis Testing Market continues to advance, supporting efforts to improve early detection, treatment outcomes, and global TB eradication strategies.
In November 2024, QIAGEN collaborated with McGill University to enhance microbiome research using advanced sequencing and bioinformatics tools. The partnership focused on developing innovative solutions for studying microbial communities, with potential applications in infectious disease diagnostics, including tuberculosis. https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2024/QIAGEN-collaborates-with-McGill-University-to-advance-microbiome-research/default.aspx
Tuberculosis Testing Market Size
Market Dynamics of Antithrombin Market
Key Drivers for Antithrombin Market
Rising global prevalence of tuberculosis (TB) and latent TB infections to boost market growth
The rising incidence of tuberculosis (TB) worldwide is a major driver of the TB testing market, as growing case numbers increase the need for early detection and effective diagnostic solutions. According to the Global Tuberculosis Report 2024, the World Health Organization (WHO) recorded 8.2 million new TB cases in 2023, marking the highest number ever reported. This alarming rise underscored the urgent need for improved screening and diagnostic capabilities to manage the spread of TB effectively. Governments and healthcare organizations responded by strengthening TB detection programs, expanding access to advanced diagnostic tools, and increasing funding for research into faster and more accurate testing methods. As the burden of TB continues to grow, demand for rapid molecular tests, digital screening tools, and point-of-care diagnostics is expected to rise. Increased awareness, combined with ongoing innovations in TB testing technology, is likely to drive significant growth in the global TB testing market.
https://www.cdc.gov/blood-clots/data-research/facts-stats/index.html
Integration of artificial intelligence (AI) and digital tools for TB diagnosis to boost market growth
The integration of artificial intelligence (AI) and digital tools is significantly driving advancements in tuberculosis (TB) diagnosis and treatment. AI-powered screening and data analysis enhance the accuracy and speed of TB detection, leading to earlier interventions and improved patient outcomes. In a study published in the Proceedings of the National Academy of Sciences, researchers from the University of California San Diego, Linnaeus Bioscience Inc., and the Center for Global Infectious Disease Research at the Seattle Children's Research Institute successfully utilized AI to screen for antimicrobial compound candidates that could be developed into new TB drug treatments. This breakthrough demonstrated AI’s potential in accelerating drug discovery and optimizing treatment strategies. As AI-based diagnostic tools become more accessible, healthcare providers can enhance TB detection in remote and resource-limited settings. With continuous investments in AI-driven healthcare innovations, the global TB testing market is expected to expand, improving diagnostic efficiency and supporting global TB eradication efforts.
Restraint Factor for the Antithrombin Market
High cost of advanced TB diagnostic tests and equipment, Will Limit Market Growth
The high cost of advanced tuberculosis (TB) diagnostic tests and equipment remains a major challenge in the market, limiting their accessibility, particularly in low- and middle-income countries. Modern diagnostic methods such as nucleic acid amplification tests (NAATs), interferon-gamma release assays (IGRAs), and automated molecular tests require expensive equipment, reagents, and maintenance. Many healthcare facilities, especially in resource-limited settings, struggle to afford these technologies, leading to reliance on traditional methods like sputum smear microscopy, which may not provide accurate or early detection. Additionally, training healthcare professionals to operate these advanced machines adds to the overall expense. The financial burden on patients and healthcare systems further restricts widespread adoption, despite the effectiveness of these diagnostics in detecting TB at an early stage. Without cost-effective solutions or increased funding from governments and international health organizations, the adoption of advanced TB diagnostic technologies may remain limited in many parts of the world.
Market Trends in Antithrombin Market
Increasing Adoption of Automated Nucleic Acid Amplification Tests (NAATs)
The adoption of automated nucleic acid amplification tests (NAATs) is growing rapidly in the tuberculosis (TB) testing market due to their high accuracy, speed, and ability to detect drug-resistant TB strains. NAATs, such as the GeneXpert and Truenat systems, provide quicker and more reliable results compared to traditional sputum smear microscopy. These tests work by detecting the genetic material of Mycobacterium tuberculosis, allowing for early diagnosis and prompt treatment. Their automated nature reduces human error, making them highly reliable for large-scale screening programs. Additionally, the World Health Organization (WHO) has endorsed NAATs as a preferred diagnostic tool, further driving their adoption. Many countries are integrating these tests into national TB control programs, particularly in high-burden areas. However, despite their advantages, the high cost of equipment and consumables remains a barrier. Efforts are underway to develop cost-effective alternatives and expand the availability of NAATs in resource-limited settings.
Rising Use of AI-Powered Imaging for TB Detection in Chest X-Rays
Artificial intelligence (AI)-powered imaging is transforming tuberculosis (TB) detection by improving the accuracy and efficiency of chest X-ray analysis. AI algorithms can analyze X-ray images to identify TB-related abnormalities, helping radiologists and healthcare workers detect the disease faster and more accurately. This technology is especially beneficial in regions with a shortage of trained radiologists, as AI-powered systems can provide automated interpretations. Organizations such as the WHO and global health initiatives are promoting AI-based TB screening as a cost-effective and scalable solution for early diagnosis. AI-driven platforms can also integrate with mobile applications, enabling remote screening in rural and underserved areas. Additionally, AI-powered imaging helps in monitoring TB progression and treatment effectiveness, improving patient outcomes. As research and development continue, AI-based TB detection is expected to become a widely used diagnostic tool, complementing molecular tests and expanding access to accurate TB diagnosis worldwide.
We have various report editions of Tuberculosis Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape of the Antithrombin Market
The Tuberculosis Testing Market is highly competitive, with several global and regional players offering advanced diagnostic solutions for TB detection and management. Leading companies such as Abbott, QIAGEN, Thermo Fisher Scientific Inc., and BD are at the forefront, leveraging their expertise in molecular diagnostics, immunoassays, and automated testing technologies to address the rising global burden of tuberculosis. These key players focus on improving test accuracy, reducing turnaround time, and expanding their product portfolios to support early diagnosis and treatment monitoring. As demand for rapid and cost-effective TB testing grows, companies are actively investing in research and development, forming strategic partnerships, and expanding their manufacturing and distribution networks to strengthen their market position. Innovations in nucleic acid amplification tests (NAATs), interferon-gamma release assays (IGRAs), and AI-powered imaging solutions are shaping the competitive landscape, allowing companies to cater to the evolving needs of healthcare providers and public health initiatives worldwide.
In April 2024, Revvity, Inc. introduced the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. Designed to streamline laboratory workflows, the Auto-Pure 2400 system offers a user-friendly interface that enhances efficiency. The combination of this advanced platform and the high accuracy of the T-SPOT.TB test benefits laboratories, healthcare providers, and patients alike. https://news.revvity.com/press-announcements/press-releases/press-release-details/2024/Revvity-Unveils-a-New-Era-of-Automated-Tuberculosis-Testing/default.aspx In May 2024, BD launched the "TB Guardianship Program" to improve awareness and education among healthcare professionals on effective tuberculosis diagnostic practices. This initiative, structured as a three-part educational series, focuses on enhancing drug susceptibility testing and TB diagnostics. https://www.bd.com/en-in/about-bd/news-and-media/news/2024/bd-launches-tb-guardianship-program
Top Companies Market Share in Tuberculosis Testing Industry: (In no particular order of Rank)
- Abbott
- QIAGEN
- Thermo Fisher Scientific Inc.
- BD
- F. Hoffmann-La Roche AG
- Hologic Inc.
- Cepheid
- DiaSorin S.p.A.
- Hain Lifescience GmbH
- Oxford Immunotec
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of the Antithrombin Market
Which Region Dominates the Antithrombin Market in 2025?
According to Cognitive Market Research, North America currently leads the Tuberculosis Testing Market and is expected to maintain its dominant position during the forecast period. This leadership is driven by well-established healthcare infrastructure, high awareness about tuberculosis (TB) screening, and strong government initiatives for TB control. The region benefits from advanced diagnostic technologies, a strong presence of key industry players, and widespread adoption of molecular testing methods such as nucleic acid amplification tests (NAATs) and interferon-gamma release assays (IGRAs). Additionally, continuous research and development (R&D) efforts, investments in innovative TB detection methods, and the availability of public health programs supporting early diagnosis further reinforce North America’s position as a key player in the global Tuberculosis Testing Market.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is projected to experience the fastest compound annual growth rate (CAGR) in the Tuberculosis Testing Market during the forecast period. The region's rapid growth is fueled by a high TB burden, increasing government efforts for TB elimination, and rising investments in healthcare infrastructure. Countries such as India, China, Indonesia, and the Philippines are at the forefront, benefiting from expanding access to TB diagnostics, large-scale screening programs, and growing adoption of advanced molecular testing technologies. Moreover, partnerships between international health organizations and local governments to improve TB detection and treatment, along with a strong push for cost-effective and rapid diagnostic solutions, are driving market expansion. With ongoing technological advancements, increasing healthcare funding, and a rising focus on early disease detection, Asia-Pacific is emerging as the fastest-growing region in the Tuberculosis Testing Market.
The current report Scope analyzes Tuberculosis Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
- Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
- Africa (Nigeria, South Africa, Rest of Africa)
Tuberculosis Testing Market Share (%) by Region (2021-2033)
Tuberculosis Testing Market Share (%) by Country
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which North America held the major market share of more than 37% of the global revenue with a market size of USD 1102.60 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2033.
United State Antithrombin market size is USD 869.95 million in 2025
According to Cognitive Market Research, the US had a major share in the Antithrombin market with a market size of USD 869.95 million in 2025 and is projected to grow at a CAGR of 4.8% during the forecast period. The U.S. Market's rising government funding for tuberculosis control programs and advanced diagnostic technologies.
Canada Antithrombin market size is USD 132.31 million in 2025
The Canadian Antithrombin market had a market share of USD 132.31 million in 2025 and is projected to grow at a CAGR of 5.8% during the forecast period. Canada’s increasing prevalence of latent TB infections among immigrant populations driving testing demand.
Mexico Antithrombin market size is USD 100.34 million in 2025
The Mexico Antithrombin market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 100.34 million in 2025..
Europe Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which Europe held the market share of more than 29% of the global revenue with a market size of USD 715.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2033.
United Kingdom Antithrombin market size is USD 145.19 million in 2025
The United Kingdom Antithrombin market had a market share of USD 145.19 million in 2025 and is projected to grow at a CAGR of 5.8% during the forecast period. In the UK, strong public health policies and increased tb screening in high-risk populations.
France Antithrombin market size is USD 79.51 million in 2025
The France Antithrombin market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 79.51 million in 2025.
Germany Antithrombin market size is USD 171.11million in 2025
According to Cognitive Market Research, the German Antithrombin market size was valued at USD 171.11 million in 2025 and is projected to grow at a CAGR of 5.2% during the forecast period. In Germany, increasing focus on early TB detection through widespread healthcare initiatives..
Italy Antithrombin market size is USD 74.32 million in 2025
The Italy Antithrombin market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 74.32 million in 2025.
Russia Antithrombin market size is USD 133.95 million in 2025
The Russia Antithrombin market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 133.95 million in 2025
Spain Antithrombin market size is USD 70.86 million in 2025
The Spain Antithrombin market is projected to witness growth at a CAGR of 4.1% during the forecast period with a market size of USD 70.86 million in 2025
Sweden Antithrombin market size is USD 26.79 million in 2025
The Sweden Antithrombin market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 26.79 million in 2025.
Denmark Antithrombin market size is USD 18.15 million in 2025
The Denmark Antithrombin market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 18.15 million in 2025
Switzerland Antithrombin market size is USD 12.96 million in 2025
The Switzerland Antithrombin market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 12.96 million in 2025.
Luxembourg Antithrombin market size is USD 10.37 million in 2025
The Luxembourg Antithrombin market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 10.37 million in 2025.
Rest of Europe Antithrombin market size is USD 120.99 million in 2025
The Rest of Europe's Antithrombin market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 120.99 million in 2025.
Asia Pacific Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which APAC held the market share of around 24% of the global revenue with a market size of USD 715.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2033.
China Antithrombin market size is USD 300.38 million in 2025
According to Cognitive Market Research, the China Antithrombin market size was valued at USD 300.38 million in 2025 and is projected to grow at a CAGR of 8.5% during the forecast period. Antithrombin surged in China due to government policies promoting TB screening and adoption of digital diagnostic solutions.
Japan Antithrombin market size is USD 98.70 million in 2025
The Japan Antithrombin market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 98.70 million in 2025
South Korea Antithrombin market size is USD 85.82 million in 2025
The South Korea Antithrombin market had a market share of USD 85.82 million in 2025 and is projected to grow at a CAGR of 8.1% during the forecast period.
India Antithrombin market size is USD 71.52 million in 2025
The Indian Antithrombin market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 71.52 million in 2025. India's high TB burden prompting large-scale government initiatives for widespread screening.
Australia Antithrombin market size is USD 37.19 million in 2025
The Australian Antithrombin market is projected to witness growth at a CAGR of 8.3% during the forecast period, with a market size of USD 37.19 million in 2025.
Singapore Antithrombin market size is USD 14.30 million in 2025
The Singapore Antithrombin market is projected to witness growth at a CAGR of 9.3% during the forecast period, with a market size of USD 14.30 million in 2025.
Taiwan Antithrombin market size is USD 27.89 million in 2025
The Taiwan Antithrombin market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 27.89 million in 2025.
South East Asia Antithrombin market size is USD 47.20 million in 2025
The South East Asia Antithrombin market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 47.20 million in 2025.
Rest of APAC Antithrombin market size is USD 32.18 million in 2025
The Rest of APAC Antithrombin market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 32.18 million in 2025.
South America Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which South America held the market share of around 3.8% of the global revenue with a market size of USD 113.24 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033.
Brazil Antithrombin market size is USD 48.47 million in 2025
According to Cognitive Market Research, the Brazil Antithrombin market size was valued at USD 48.47 million in 2025 and is projected to grow at a CAGR of 7.1% during the forecast period. Antithrombin flourished in Brazil due to national TB control programs boosting demand for accurate and accessible testing.
Argentina Antithrombin market size is USD 19.02 million in 2025
Argentina's Antithrombin market had a market share of USD 19.02 million in 2025 and is projected to grow at a CAGR of 7.4% during the forecast period. Argentina's growing adoption of molecular diagnostic techniques for TB detection.
Colombia Antithrombin market size is USD 10.08 million in 2025
Colombia Antithrombin market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 10.08 million in 2025
Peru Antithrombin market size is USD 9.29 million in 2025
Peru Antithrombin market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 9.29 million in 2025.
Chile Antithrombin market size is USD 8.15 million in 2025
Chile Antithrombin market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 8.15 million in 2025
Rest of South America Antithrombin market size is USD 18.23 million in 2025
The Rest of South America's Antithrombin market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 18.23 million in 2025.
Middle East Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which the Middle East held the major market share of around 4% of the global revenue with a market size of USD 119.20 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2033..
Qatar Antithrombin market size is USD 9.54 million in 2025
The Qatar Antithrombin market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 9.54 million in 2025. Antithrombin sales flourish due to the government-driven TB screening for migrant workers and international travelers.
Saudi Arabia Antithrombin market size is USD 41.96 million in 2025
The Saudi Arabia Antithrombin market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 41.96 million in 2025.
Turkey Antithrombin market size is USD 9.54 million in 2025
The Turkey Antithrombin market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 9.54 million in 2025. Antithrombin sales flourished in Turkey due to the national TB prevention strategies enhancing the availability of rapid diagnostics..
UAE Antithrombin market size is USD 24.56 million in 2025
The UAE Antithrombin market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 24.56 million in 2025.
Egypt Antithrombin market size is USD 2.37 million in 2025
The Egypt Antithrombin market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 7.15 million in 2025.
Rest of the Middle East Antithrombin market size is USD 26.46 million in 2025
The Rest of the Middle East Antithrombin market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 26.46 million in 2025
Africa Tuberculosis Testing Market Analysis
According to Cognitive Market Research, the global Antithrombin market size was estimated at USD 2980 Million, out of which the Africa held the major market share of around 2.20% of the global revenue with a market size of USD 65.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.90% from 2025 to 2033.
Nigeria Antithrombin market size is USD 5.24 million in 2025
The Nigeria Antithrombin market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 5.24 million in 2025. Antithrombin sales flourish due to the high TB prevalence necessitating large-scale diagnostic initiatives and funding.
South Africa Antithrombin market size is USD 23.08 million in 2025
The South Africa Antithrombin market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 23.08 million in 2025.
Rest of Africa Antithrombin market size is USD 37.24 million in 2025
The Rest of Africa Antithrombin market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 37.24 million in 2025.
Tuberculosis Testing Market Analysis
Global Tuberculosis Testing Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Tuberculosis Testing Industry growth. Tuberculosis Testing market has been segmented with the help of its Test Type Outlook:, End User Outlook: , and others. Tuberculosis Testing market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Antithrombin Market?
Antithrombin Market Test Type Segment Analysis
According to Cognitive Market Research, Nucleic Acid Testing (NAT) is the dominant test type in the Tuberculosis Testing Market due to its high accuracy, rapid results, and ability to detect TB even in low-bacterial-load samples. NAT methods, including polymerase chain reaction (PCR)-based assays and Xpert MTB/RIF tests, have become the preferred choice in many healthcare settings. Their ability to provide quick and reliable diagnoses, along with drug resistance detection, makes them essential for TB control programs. Additionally, government initiatives and global health organizations actively support the adoption of NAT to improve TB detection rates. As a result, NAT continues to lead the market, particularly in regions with strong healthcare infrastructures and funding for advanced diagnostics.
The Xpert Test is the fastest-growing segment in the Tuberculosis Testing Market, primarily due to its automated, cartridge-based system that delivers rapid and accurate TB diagnoses, including drug-resistant strains. This test is gaining popularity in low- and middle-income countries because it requires minimal laboratory infrastructure and delivers results within hours. The World Health Organization (WHO) and various public health organizations are actively promoting the use of Xpert MTB/RIF as a frontline diagnostic tool. Additionally, rising investments in portable and decentralized testing solutions, particularly in high TB-burden regions like Asia-Pacific and Africa, are further fueling the growth of this segment. Its ability to provide quick, reliable, and accessible testing solutions makes it the fastest-growing TB test type.
Tuberculosis Testing Market Share (%) by Test Type Outlook: in 2021-2033
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Tuberculosis Testing Industry. Request a Free Sample PDF!
Antithrombin Market End User Segment Analysis
According to Cognitive Market Research, hospital laboratories are the dominant end-user in the Tuberculosis Testing Market due to their high patient volume, access to advanced diagnostic equipment, and ability to provide comprehensive TB testing services. These facilities perform a wide range of TB tests, including NAT, smear microscopy, and culture-based methods, ensuring accurate diagnosis and treatment planning. Hospitals also serve as primary healthcare centers for TB patients, particularly in urban settings where medical infrastructure is well-developed. Additionally, government-backed screening programs and collaborations with global health organizations enable hospitals to maintain their leadership in TB diagnostics. As a result, hospital laboratories remain the most significant contributors to the overall TB testing market.
In the Antithrombin Market, Physician’s Office Laboratories are the fastest-growing end-user segment in the Tuberculosis Testing Market, driven by the rising demand for point-of-care (POC) testing and the increasing availability of portable diagnostic solutions. These facilities allow faster TB detection, reducing the need for hospital visits and improving patient convenience. The adoption of rapid diagnostic tools, such as Xpert MTB/RIF and interferon-gamma release assays (IGRAs), enables quick and effective TB screening in outpatient settings. Additionally, governments and healthcare organizations are focusing on decentralized TB testing strategies to enhance accessibility, particularly in remote and underserved areas. As more primary care providers integrate TB diagnostics into their services, physician’s office laboratories are experiencing rapid market growth.
Tuberculosis Testing Market Share (%) by End User Outlook: in 2021-2033
2021
2025
2033
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Conclusion
- The global Antithrombin market will expand significantly by 6.20% CAGR between 2025 and 2033.
- Nucleic Acid Testing (NAT) is expected to dominate the Tuberculosis Testing Market as it is widely used for rapid, accurate, and early detection of TB, including drug-resistant strains.
- Hospital Laboratories hold the largest market share in the end-user segment, as they serve as primary diagnostic centers equipped with advanced testing technologies.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Tuberculosis Testing Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Tuberculosis Testing Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Test Type Outlook: | Chest X-Ray, Culture-Based Tests, Interferon-Gamma Release Assays (IGRA), Mantoux Test (Tuberculin Skin Test), Nucleic Acid Testing (NAT), Xpert Test, Serological Tests, Smear Microscopy |
| End User Outlook: | Academic and Research Institutes, Hospital Laboratories, Physician's Office Laboratories, Reference Laboratories |
| List of Competitors | Abbott, QIAGEN, Thermo Fisher Scientific Inc., BD, F. Hoffmann-La Roche AG, Hologic Inc., Cepheid, DiaSorin S.p.A., Hain Lifescience GmbH, Oxford Immunotec |
This chapter will help you gain GLOBAL Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review Global Tuberculosis Testing Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Tuberculosis Testing Revenue Market Size, Trend Analysis 2021 - 2033
-
1.2 Global Tuberculosis Testing Market Size By Regions 2021 - 2033
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Tuberculosis Testing Revenue Market Size By Region
-
-
1.3 Global Tuberculosis Testing Market Size By Test Type Outlook: 2021 - 2033
-
1.3.1 Chest X-Ray Market Size
-
1.3.2 Culture-Based Tests Market Size
-
1.3.3 Interferon-Gamma Release Assays (IGRA) Market Size
-
1.3.4 Mantoux Test (Tuberculin Skin Test) Market Size
-
1.3.5 Nucleic Acid Testing (NAT) Market Size
-
1.3.6 Xpert Test Market Size
-
1.3.7 Serological Tests Market Size
-
1.3.8 Smear Microscopy Market Size
-
-
1.4 Global Tuberculosis Testing Market Size By End User Outlook: 2021 - 2033
-
1.4.1 Academic and Research Institutes Market Size
-
1.4.2 Hospital Laboratories Market Size
-
1.4.3 Physician's Office Laboratories Market Size
-
1.4.4 Reference Laboratories Market Size
-
-
1.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.6 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.6.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
1.6.2 Global Market Revenue Split By Test Type Outlook:
-
1.6.3 Global Market Revenue Split By End User Outlook:
-
1.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review North America Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Tuberculosis Testing Market Size 2021 - 2033
-
2.1.1 North America Tuberculosis Testing Market Size By Country 2021 - 2033
-
2.1.2 North America Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
2.1.2.1 North America Chest X-Ray Market Size
-
2.1.2.2 North America Culture-Based Tests Market Size
-
2.1.2.3 North America Interferon-Gamma Release Assays (IGRA) Market Size
-
2.1.2.4 North America Mantoux Test (Tuberculin Skin Test) Market Size
-
2.1.2.5 North America Nucleic Acid Testing (NAT) Market Size
-
2.1.2.6 North America Xpert Test Market Size
-
2.1.2.7 North America Serological Tests Market Size
-
2.1.2.8 North America Smear Microscopy Market Size
-
-
2.1.3 North America Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
2.1.3.1 North America Academic and Research Institutes Market Size
-
2.1.3.2 North America Hospital Laboratories Market Size
-
2.1.3.3 North America Physician's Office Laboratories Market Size
-
2.1.3.4 North America Reference Laboratories Market Size
-
-
-
2.2 United States Market Size 2021 - 2033
-
2.2.1 United States Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
2.2.2 United States Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
2.3 Canada Market Size 2021 - 2033
-
2.3.1 Canada Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
2.3.2 Canada Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
2.4 Mexico Market Size 2021 - 2033
-
2.4.1 Mexico Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
2.4.2 Mexico Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter will help you gain Europe Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review Europe Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Tuberculosis Testing Market Size 2021 - 2033
-
3.1.1 Europe Tuberculosis Testing Market Size By Country 2021 - 2033
-
3.1.2 Europe Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.1.2.1 Europe Chest X-Ray Market Size
-
3.1.2.2 Europe Culture-Based Tests Market Size
-
3.1.2.3 Europe Interferon-Gamma Release Assays (IGRA) Market Size
-
3.1.2.4 Europe Mantoux Test (Tuberculin Skin Test) Market Size
-
3.1.2.5 Europe Nucleic Acid Testing (NAT) Market Size
-
3.1.2.6 Europe Xpert Test Market Size
-
3.1.2.7 Europe Serological Tests Market Size
-
3.1.2.8 Europe Smear Microscopy Market Size
-
-
3.1.3 Europe Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
3.1.3.1 Europe Academic and Research Institutes Market Size
-
3.1.3.2 Europe Hospital Laboratories Market Size
-
3.1.3.3 Europe Physician's Office Laboratories Market Size
-
3.1.3.4 Europe Reference Laboratories Market Size
-
-
-
3.2 United Kingdom Market Size 2021 - 2033
-
3.2.1 United Kingdom Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.2.2 United Kingdom Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.3 France Market Size 2021 - 2033
-
3.3.1 France Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.3.2 France Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.4 Germany Market Size 2021 - 2033
-
3.4.1 Germany Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.4.2 Germany Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.5 Italy Market Size 2021 - 2033
-
3.5.1 Italy Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.5.2 Italy Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.6 Russia Market Size 2021 - 2033
-
3.6.1 Russia Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.6.2 Russia Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.7 Spain Market Size 2021 - 2033
-
3.7.1 Spain Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.7.2 Spain Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.8 Sweden Market Size 2021 - 2033
-
3.8.1 Sweden Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.8.2 Sweden Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.9 Denmark Market Size 2021 - 2033
-
3.9.1 Denmark Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.9.2 Denmark Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.10 Switzerland Market Size 2021 - 2033
-
3.10.1 Switzerland Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.10.2 Switzerland Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.11 Luxembourg Market Size 2021 - 2033
-
3.11.1 Luxembourg Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.11.2 Luxembourg Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
3.12 Rest of Europe Market Size 2021 - 2033
-
3.12.1 Rest of Europe Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
3.12.2 Rest of Europe Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter will help you gain Asia Pacific Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review Asia Pacific Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Tuberculosis Testing Market Size 2021 - 2033
-
4.1.1 Asia Pacific Tuberculosis Testing Market Size By Country 2021 - 2033
-
4.1.2 Asia Pacific Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.1.2.1 Asia Pacific Chest X-Ray Market Size
-
4.1.2.2 Asia Pacific Culture-Based Tests Market Size
-
4.1.2.3 Asia Pacific Interferon-Gamma Release Assays (IGRA) Market Size
-
4.1.2.4 Asia Pacific Mantoux Test (Tuberculin Skin Test) Market Size
-
4.1.2.5 Asia Pacific Nucleic Acid Testing (NAT) Market Size
-
4.1.2.6 Asia Pacific Xpert Test Market Size
-
4.1.2.7 Asia Pacific Serological Tests Market Size
-
4.1.2.8 Asia Pacific Smear Microscopy Market Size
-
-
4.1.3 Asia Pacific Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
4.1.3.1 Asia Pacific Academic and Research Institutes Market Size
-
4.1.3.2 Asia Pacific Hospital Laboratories Market Size
-
4.1.3.3 Asia Pacific Physician's Office Laboratories Market Size
-
4.1.3.4 Asia Pacific Reference Laboratories Market Size
-
-
-
4.2 China Tuberculosis Testing Market Size 2021 - 2033
-
4.2.1 China Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.2.2 China Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.3 Japan Tuberculosis Testing Market Size 2021 - 2033
-
4.3.1 Japan Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.3.2 Japan Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.4 South Korea Tuberculosis Testing Market Size 2021 - 2033
-
4.4.1 South Korea Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.4.2 South Korea Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.5 India Tuberculosis Testing Market Size 2021 - 2033
-
4.5.1 India Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.5.2 India Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.6 Australia Tuberculosis Testing Market Size 2021 - 2033
-
4.6.1 Australia Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.6.2 Australia Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.7 Singapore Tuberculosis Testing Market Size 2021 - 2033
-
4.7.1 Singapore Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.7.2 Singapore Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.8 Taiwan Tuberculosis Testing Market Size 2021 - 2033
-
4.8.1 Taiwan Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.8.2 Taiwan Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.9 South East Asia Tuberculosis Testing Market Size 2021 - 2033
-
4.9.1 South East Asia Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.9.2 South East Asia Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
4.10 Rest of APAC Tuberculosis Testing Market Size 2021 - 2033
-
4.10.1 Rest of APAC Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
4.10.2 Rest of APAC Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter will help you gain South America Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review South America Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Tuberculosis Testing Market Size 2021 - 2033
-
5.1.1 South America Tuberculosis Testing Market Size By Country 2021 - 2033
-
5.1.2 South America Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.1.2.1 South America Chest X-Ray Market Size
-
5.1.2.2 South America Culture-Based Tests Market Size
-
5.1.2.3 South America Interferon-Gamma Release Assays (IGRA) Market Size
-
5.1.2.4 South America Mantoux Test (Tuberculin Skin Test) Market Size
-
5.1.2.5 South America Nucleic Acid Testing (NAT) Market Size
-
5.1.2.6 South America Xpert Test Market Size
-
5.1.2.7 South America Serological Tests Market Size
-
5.1.2.8 South America Smear Microscopy Market Size
-
-
5.1.3 South America Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
5.1.3.1 South America Academic and Research Institutes Market Size
-
5.1.3.2 South America Hospital Laboratories Market Size
-
5.1.3.3 South America Physician's Office Laboratories Market Size
-
5.1.3.4 South America Reference Laboratories Market Size
-
-
-
5.2 Brazil Tuberculosis Testing Market Size 2021 - 2033
-
5.2.1 Brazil Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.2.2 Brazil Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
5.3 Argentina Tuberculosis Testing Market Size 2021 - 2033
-
5.3.1 Argentina Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.3.2 Argentina Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
5.4 Colombia Tuberculosis Testing Market Size 2021 - 2033
-
5.4.1 Colombia Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.4.2 Colombia Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
5.5 Peru Tuberculosis Testing Market Size 2021 - 2033
-
5.5.1 Peru Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.5.2 Peru Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
5.6 Chile Tuberculosis Testing Market Size 2021 - 2033
-
5.6.1 Chile Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.6.2 Chile Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
5.7 Rest of South America Tuberculosis Testing Market Size 2021 - 2033
-
5.7.1 Rest of South America Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
5.7.2 Rest of South America Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review Middle East Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
-
6.1 Middle East Tuberculosis Testing Market Size 2021 - 2033
-
6.1.1 Middle East Tuberculosis Testing Market Size By Country 2021 - 2033
-
6.1.2 Middle East Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.1.2.1 Middle East Chest X-Ray Market Size
-
6.1.2.2 Middle East Culture-Based Tests Market Size
-
6.1.2.3 Middle East Interferon-Gamma Release Assays (IGRA) Market Size
-
6.1.2.4 Middle East Mantoux Test (Tuberculin Skin Test) Market Size
-
6.1.2.5 Middle East Nucleic Acid Testing (NAT) Market Size
-
6.1.2.6 Middle East Xpert Test Market Size
-
6.1.2.7 Middle East Serological Tests Market Size
-
6.1.2.8 Middle East Smear Microscopy Market Size
-
-
6.1.3 Middle East Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
6.1.3.1 Middle East Academic and Research Institutes Market Size
-
6.1.3.2 Middle East Hospital Laboratories Market Size
-
6.1.3.3 Middle East Physician's Office Laboratories Market Size
-
6.1.3.4 Middle East Reference Laboratories Market Size
-
-
-
6.2 Saudi Arabia Tuberculosis Testing Market Size 2021 - 2033
-
6.2.1 Saudi Arabia Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.2.2 Saudi Arabia Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
6.3 Turkey Tuberculosis Testing Market Size 2021 - 2033
-
6.3.1 Turkey Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.3.2 Turkey Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
6.4 UAE Tuberculosis Testing Market Size 2021 - 2033
-
6.4.1 UAE Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.4.2 UAE Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
6.5 Egypt Tuberculosis Testing Market Size 2021 - 2033
-
6.5.1 Egypt Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.5.2 Egypt Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
6.6 Qatar Tuberculosis Testing Market Size 2021 - 2033
-
6.6.1 Qatar Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.6.2 Qatar Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
6.7 Rest of Middle East Tuberculosis Testing Market Size 2021 - 2033
-
6.7.1 Rest of Middle East Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
6.7.2 Rest of Middle East Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Tuberculosis Testing. Further deep in this chapter, you will be able to review Middle East Tuberculosis Testing Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
-
7.1 Africa Tuberculosis Testing Market Size 2021 - 2033
-
7.1.1 Africa Tuberculosis Testing Market Size By Country 2021 - 2033
-
7.1.2 Africa Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
7.1.2.1 Africa Chest X-Ray Market Size
-
7.1.2.2 Africa Culture-Based Tests Market Size
-
7.1.2.3 Africa Interferon-Gamma Release Assays (IGRA) Market Size
-
7.1.2.4 Africa Mantoux Test (Tuberculin Skin Test) Market Size
-
7.1.2.5 Africa Nucleic Acid Testing (NAT) Market Size
-
7.1.2.6 Africa Xpert Test Market Size
-
7.1.2.7 Africa Serological Tests Market Size
-
7.1.2.8 Africa Smear Microscopy Market Size
-
-
7.1.3 Africa Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
7.1.3.1 Africa Academic and Research Institutes Market Size
-
7.1.3.2 Africa Hospital Laboratories Market Size
-
7.1.3.3 Africa Physician's Office Laboratories Market Size
-
7.1.3.4 Africa Reference Laboratories Market Size
-
-
-
7.2 Nigeria Tuberculosis Testing Market Size 2021 - 2033
-
7.2.1 Nigeria Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
7.2.2 Nigeria Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
7.3 South Africa Tuberculosis Testing Market Size 2021 - 2033
-
7.3.1 South Africa Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
7.3.2 South Africa Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
-
7.4 Rest of Africa Tuberculosis Testing Market Size 2021 - 2033
-
7.4.1 Rest of Africa Tuberculosis Testing Market Size by Test Type Outlook: 2021 - 2033
-
7.4.2 Rest of Africa Tuberculosis Testing Market Size by End User Outlook: 2021 - 2033
-
This chapter provides an in-depth analysis of the market share among key competitors of Tuberculosis Testing. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2024
-
8.1.2 Global Tuberculosis Testing Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability) Sample Format
-
8.2.1 Abbott
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 QIAGEN
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Thermo Fisher Scientific Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 BD
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 F. Hoffmann-La Roche AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Hologic Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Cepheid
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 DiaSorin S.p.A.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Hain Lifescience GmbH
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Oxford Immunotec
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Impact of Trump's Tariff War on Tuberculosis Testing Market Data
-
9.1.1 Policy Shifts That Influence the Tuberculosis Testing Market
-
9.1.2 Tariff and their Long-Term Impact on the Tuberculosis Testing Market
-
9.1.3 Trade Wars and Supply Chain Changes in the Tuberculosis Testing Market
-
9.1.4 Regional and Geopolitical implications in the Tuberculosis Testing Market
-
9.1.5 Tax Reforms and Business Expansion in the Tuberculosis Testing Market
-
9.1.6 Investor Sentiment in Key Segments of the Tuberculosis Testing Market
-
9.1.7 Environmental Rollbacks and ESG Implications in the Tuberculosis Testing Market
-
9.1.8 Consumer Behavior and Brand Perception in the Politicized in Tuberculosis Testing Market
-
9.1.9 Strategic takeaways for future administration in Tuberculosis Testing Market
-
-
9.2 Market Drivers
-
9.3 Market Restraints
-
9.4 Market Trends
-
9.5 Market Opportunity
-
9.6 Technological Road Map (Subject to Data Availability)
-
9.7 Product Life Cycle (Subject to Data Availability)
-
9.8 Consumer Preference Analysis
-
9.9 Market Attractiveness Analysis
-
9.10 PESTEL Analysis
-
9.10.1 Political Factors
-
9.10.2 Economic Factors
-
9.10.3 Social Factors
-
9.10.4 Technological Factors
-
9.10.5 Legal Factors
-
9.10.6 Environmental Factors
-
-
9.11 Industrial Chain Analysis (Subject to Data Availability)
-
9.11.1 Industry Chain Analysis
-
9.11.2 Manufacturing Cost Analysis
-
9.11.3 Supply Side Analysis
-
9.11.3.1 Raw Material Analysis
-
9.11.3.2 Raw Material Procurement Analysis
-
9.11.3.3 Raw Material Price Trend Analysis
-
-
-
9.12 Porter’s Five Forces Analysis
-
9.12.1 Bargaining Power of Suppliers
-
9.12.2 Bargaining Power of Buyers
-
9.12.3 Threat of New Entrants
-
9.12.4 Threat of Substitutes
-
9.12.5 Degree of Competition
-
-
9.13 Patent Analysis (Subject to Data Availability)
-
9.14 ESG Analysis
Segmentation Test Type Outlook: Analysis 2019 -2031, will provide market size split by Test Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Test Type Outlook: Analysis 2021 - 2033
-
10.1 Chest X-Ray
-
10.1.1 Global Tuberculosis Testing Revenue Market Size and Share by Chest X-Ray 2021 - 2033
-
-
10.2 Culture-Based Tests
-
10.2.1 Global Tuberculosis Testing Revenue Market Size and Share by Culture-Based Tests 2021 - 2033
-
-
10.3 Interferon-Gamma Release Assays (IGRA)
-
10.3.1 Global Tuberculosis Testing Revenue Market Size and Share by Interferon-Gamma Release Assays (IGRA) 2021 - 2033
-
-
10.4 Mantoux Test (Tuberculin Skin Test)
-
10.4.1 Global Tuberculosis Testing Revenue Market Size and Share by Mantoux Test (Tuberculin Skin Test) 2021 - 2033
-
-
10.5 Nucleic Acid Testing (NAT)
-
10.5.1 Global Tuberculosis Testing Revenue Market Size and Share by Nucleic Acid Testing (NAT) 2021 - 2033
-
-
10.6 Xpert Test
-
10.6.1 Global Tuberculosis Testing Revenue Market Size and Share by Xpert Test 2021 - 2033
-
-
10.7 Serological Tests
-
10.7.1 Global Tuberculosis Testing Revenue Market Size and Share by Serological Tests 2021 - 2033
-
-
10.8 Smear Microscopy
-
10.8.1 Global Tuberculosis Testing Revenue Market Size and Share by Smear Microscopy 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Outlook: Analysis 2021 - 2033
-
11.1 Academic and Research Institutes
-
11.1.1 Global Tuberculosis Testing Revenue Market Size and Share by Academic and Research Institutes 2021 - 2033
-
-
11.2 Hospital Laboratories
-
11.2.1 Global Tuberculosis Testing Revenue Market Size and Share by Hospital Laboratories 2021 - 2033
-
-
11.3 Physician's Office Laboratories
-
11.3.1 Global Tuberculosis Testing Revenue Market Size and Share by Physician's Office Laboratories 2021 - 2033
-
-
11.4 Reference Laboratories
-
11.4.1 Global Tuberculosis Testing Revenue Market Size and Share by Reference Laboratories 2021 - 2033
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Tuberculosis Testing market
Chapter 12 Research Findings
-
12.1 Key Takeaways
-
12.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
12.3 Assumptions and Acronyms
Chapter 13 Research Methodology and Sources
-
13.1 Primary Data Collection
-
13.1.1 Steps for Primary Data Collection
-
13.1.1.1 Identification of KOL
-
-
13.1.2 Backward Integration
-
13.1.3 Forward Integration
-
13.1.4 How Primary Research Help Us
-
13.1.5 Modes of Primary Research
-
-
13.2 Secondary Research
-
13.2.1 How Secondary Research Help Us
-
13.2.2 Sources of Secondary Research
-
-
13.3 Data Validation
-
13.3.1 Data Triangulation
-
13.3.2 Top Down & Bottom Up Approach
-
13.3.3 Cross check KOL Responses with Secondary Data
-
-
13.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1 Data Gathering
- 1.1 Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.1.1.1 Identification of KOL
- 1.1.1.2 Backward Integration
- 1.1.1.3 Forward Integration
- 1.1.1.4 How Primary Research Help Us
- 1.1.1.5 Modes of Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.2 Secondary Research
- 1.2.1 How Secondary Research Help Us
- 1.2.2 Sources of Secondary Research
- 1.1 Primary Research
- 2 Data Validation
- 2.1 Cross check KOL Responses with Secondary Data
- 2.2 Top Down & Bottom Up Approach
- 2.3 Data Triangulation
- 3 Data Representation
Key Questions Answered By Tuberculosis Testing Market Report 2025
| Why Chest X-Ray have a significant impact on Tuberculosis Testing market? |
| What are the key factors affecting the Chest X-Ray and Culture-Based Tests of Tuberculosis Testing Market? |
| What is the CAGR/Growth Rate of Academic and Research Institutes during the forecast period? |
| By type, which segment accounted for largest share of the global Tuberculosis Testing Market? |
| Which region is expected to dominate the global Tuberculosis Testing Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
